Literature DB >> 25429154

PMP22 is critical for actin-mediated cellular functions and for establishing lipid rafts.

Sooyeon Lee1, Stephanie Amici1, Hagai Tavori2, Waylon M Zeng1, Steven Freeland1, Sergio Fazio2, Lucia Notterpek3.   

Abstract

Haploinsufficiency of peripheral myelin protein 22 (PMP22) causes hereditary neuropathy with liability to pressure palsies, a peripheral nerve lesion induced by minimal trauma or compression. As PMP22 is localized to cholesterol-enriched membrane domains that are closely linked with the underlying actin network, we asked whether the myelin instability associated with PMP22 deficiency could be mediated by involvement of the protein in actin-dependent cellular functions and/or lipid raft integrity. In peripheral nerves and cells from mice with PMP22 deletion, we assessed the organization of filamentous actin (F-actin), and actin-dependent cellular functions. Using in vitro models, we discovered that, in the absence of PMP22, the migration and adhesion capacity of Schwann cells and fibroblasts are similarly impaired. Furthermore, PMP22-deficient Schwann cells produce shortened myelin internodes, and display compressed axial cell length and collapsed lamellipodia. During early postnatal development, F-actin-enriched Schmidt-Lanterman incisures do not form properly in nerves from PMP22(-/-) mice, and the expression and localization of molecules associated with uncompacted myelin domains and lipid rafts, including flotillin-1, cholesterol, and GM1 ganglioside, are altered. In addition, we identified changes in the levels and distribution of cholesterol and ApoE when PMP22 is absent. Significantly, cholesterol supplementation of the culture medium corrects the elongation and migration deficits of PMP22(-/-) Schwann cells, suggesting that the observed functional impairments are directly linked with cholesterol deficiency of the plasma membrane. Our findings support a novel role for PMP22 in the linkage of the actin cytoskeleton with the plasma membrane, likely through regulating the cholesterol content of lipid rafts.
Copyright © 2014 the authors 0270-6474/14/3416140-13$15.00/0.

Entities:  

Keywords:  Schwann cell; actin cytoskeleton; cholesterol; lipid rafts; myelin; neuropathy

Mesh:

Substances:

Year:  2014        PMID: 25429154      PMCID: PMC4244477          DOI: 10.1523/JNEUROSCI.1908-14.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  67 in total

1.  Expression of the large myelin-associated glycoprotein isoform during the development in the mouse peripheral nervous system.

Authors:  T Inuzuka; N Fujita; S Sato; H Baba; R Nakano; H Ishiguro; T Miyatake
Journal:  Brain Res       Date:  1991-10-18       Impact factor: 3.252

2.  Co-localization of the myelin-associated glycoprotein and the microfilament components, F-actin and spectrin, in Schwann cells of myelinated nerve fibres.

Authors:  B D Trapp; S B Andrews; A Wong; M O'Connell; J W Griffin
Journal:  J Neurocytol       Date:  1989-02

3.  Cell attachment properties of collagen type VI and Arg-Gly-Asp dependent binding to its alpha 2(VI) and alpha 3(VI) chains.

Authors:  M Aumailley; K Mann; H von der Mark; R Timpl
Journal:  Exp Cell Res       Date:  1989-04       Impact factor: 3.905

4.  Genes specifically expressed at growth arrest of mammalian cells.

Authors:  C Schneider; R M King; L Philipson
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

5.  Trembler mouse carries a point mutation in a myelin gene.

Authors:  U Suter; A A Welcher; T Ozcelik; G J Snipes; B Kosaras; U Francke; S Billings-Gagliardi; R L Sidman; E M Shooter
Journal:  Nature       Date:  1992-03-19       Impact factor: 49.962

6.  Alterations of cholesterol synthesis precursors (7-dehydrocholesterol, 7-dehydrodesmosterol, desmosterol) in dysmyelinating neurological mutant mouse (quaking, shiverer and trembler) in the PNS and the CNS.

Authors:  J M Bourre; M Clément; D Gérard; J Chaudiére
Journal:  Biochim Biophys Acta       Date:  1989-08-22

7.  Alteration of sulfatide synthesis in control and Trembler mice during Wallerian degeneration and remyelination.

Authors:  J M Bourre; O Dumont; M Gumpel; C Cassagne
Journal:  Neurochem Pathol       Date:  1984

8.  Serum proprotein convertase subtilisin/kexin type 9 and cell surface low-density lipoprotein receptor: evidence for a reciprocal regulation.

Authors:  Hagai Tavori; Daping Fan; John L Blakemore; Patricia G Yancey; Lei Ding; Macrae F Linton; Sergio Fazio
Journal:  Circulation       Date:  2013-05-20       Impact factor: 29.690

9.  CaMKIIβ regulates oligodendrocyte maturation and CNS myelination.

Authors:  Christopher T Waggener; Jeffrey L Dupree; Ype Elgersma; Babette Fuss
Journal:  J Neurosci       Date:  2013-06-19       Impact factor: 6.167

10.  Liposomes to target peripheral neurons and Schwann cells.

Authors:  Sooyeon Lee; Ana Tari Ashizawa; Kwang Sik Kim; Darin J Falk; Lucia Notterpek
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

View more
  25 in total

1.  A dual role for Integrin α6β4 in modulating hereditary neuropathy with liability to pressure palsies.

Authors:  Yannick Poitelon; Vittoria Matafora; Nicholas Silvestri; Desirée Zambroni; Claire McGarry; Nora Serghany; Thomas Rush; Domenica Vizzuso; Felipe A Court; Angela Bachi; Lawrence Wrabetz; Maria Laura Feltri
Journal:  J Neurochem       Date:  2018-02-13       Impact factor: 5.372

2.  PMP22 Regulates Cholesterol Trafficking and ABCA1-Mediated Cholesterol Efflux.

Authors:  Ye Zhou; Joshua R Miles; Hagai Tavori; Min Lin; Habibeh Khoshbouei; David R Borchelt; Hannah Bazick; Gary E Landreth; Sooyeon Lee; Sergio Fazio; Lucia Notterpek
Journal:  J Neurosci       Date:  2019-05-06       Impact factor: 6.167

3.  PMP22 antisense oligonucleotides reverse Charcot-Marie-Tooth disease type 1A features in rodent models.

Authors:  Hien Tran Zhao; Sagar Damle; Karli Ikeda-Lee; Steven Kuntz; Jian Li; Apoorva Mohan; Aneeza Kim; Gene Hung; Mark A Scheideler; Steven S Scherer; John Svaren; Eric E Swayze; Holly B Kordasiewicz
Journal:  J Clin Invest       Date:  2017-12-04       Impact factor: 14.808

4.  Direct relationship between increased expression and mistrafficking of the Charcot-Marie-Tooth-associated protein PMP22.

Authors:  Justin T Marinko; Bruce D Carter; Charles R Sanders
Journal:  J Biol Chem       Date:  2020-07-09       Impact factor: 5.157

5.  Functional Recovery Occurs Even After Partial Remyelination of Axon-Meshed Median and Ulnar Nerves in Mice.

Authors:  Ana Elisa Speck; Jocemar Ilha; Daniel Fernandes Martins; Franciane Bobinski; Ana Paula Luiz; Adair Roberto Soares Dos Santos; Alessandra Swarowsky; Aderbal Silva Aguiar
Journal:  Neurochem Res       Date:  2019-08-26       Impact factor: 3.996

6.  The Actin Cytoskeleton in Myelinating Cells.

Authors:  Tanya L Brown; Wendy B Macklin
Journal:  Neurochem Res       Date:  2019-03-07       Impact factor: 3.996

7.  A novel histone deacetylase 6 inhibitor improves myelination of Schwann cells in a model of Charcot-Marie-Tooth disease type 1A.

Authors:  Nina Ha; Young Il Choi; Namhee Jung; Ju Young Song; Dae Kwon Bae; Min Cheol Kim; Yong Jae Lee; Hyeseung Song; Geon Kwak; Soyeon Jeong; Saeyoung Park; Soo Hyun Nam; Sung-Chul Jung; Byung-Ok Choi
Journal:  Br J Pharmacol       Date:  2020-09-27       Impact factor: 8.739

8.  Peripheral myelin protein 22 modulates store-operated calcium channel activity, providing insights into Charcot-Marie-Tooth disease etiology.

Authors:  Carlos G Vanoye; Masayoshi Sakakura; Rose M Follis; Alexandra J Trevisan; Malathi Narayan; Jun Li; Charles R Sanders; Bruce D Carter
Journal:  J Biol Chem       Date:  2019-06-18       Impact factor: 5.157

9.  Proteomic Analysis of Lipid Raft-Like Detergent-Resistant Membranes of Lens Fiber Cells.

Authors:  Zhen Wang; Kevin L Schey
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

10.  Ion mobility-mass spectrometry reveals the role of peripheral myelin protein dimers in peripheral neuropathy.

Authors:  Sarah M Fantin; Kristine F Parson; Pramod Yadav; Brock Juliano; Geoffrey C Li; Charles R Sanders; Melanie D Ohi; Brandon T Ruotolo
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.